Mainz Biomed to Present at the 35th Annual Piper Sandler Healthcare Conference
BERKELEY, Calif. and MAINZ, Germany, Nov. 20, 2023 (GLOBE NEWSWIRE) -- Mainz Biomed N.V. (NASDAQ:MYNZ) (“Mainz Biomed” or the “Company”), a molecular genetics diagnostic company specializing in the early detection of cancer, announces that Guido Baechler, Chief Executive Officer, and Bill Caragol, Chief Financial Officer, will present at the 35th Annual Piper Sandler Healthcare Conference taking place on the 28-30 November, 2023 in New York, NY, USA.
The conference will bring together key industry executives, investors and Piper Sandler professionals to provide multiple perspectives, investigate critical trends and identify the impactful leaders in the healthcare market.
Mainz Biomed’s presentation will take place on November 29th at 8.50am ET, and Guido Baechler and Bill Caragol will be available for 1-on-1 meetings with investors throughout that day.
About Manz Biomed N.V.
For media inquiries -
In the U.S.:
For investor inquiries, please contact [email protected]
Future of Work Expo #TECHSUPERSHOW Booth Crawl
Cybersecurity Solutions Session